Comparative Antiviral Efficacy of Generic Sofosbuvir versus Brand Name Sofosbuvir with Ribavirin for the Treatment of Hepatitis C

<div>Virologic response among patients with available sustained virologic response (SVR). (a) Percentage of all patients. (b) Percentage of genotype 3 patients. (c) Percentage of all patients with compensated cirrhosis. (d) Percentage of all patients excluding decompensated cirrhosis.</div>

Interdisciplinary Perspectives on Infectious Diseases

fig1

Figure 1

Figure 1: Comparative Antiviral Efficacy of Generic Sofosbuvir versus Brand Name Sofosbuvir with Ribavirin for the Treatment of Hepatitis C 